[Clinico-laboratory characteristics and treatment of patients with trichinosis].
The severity of clinical features of trichinosis and cardiac involvement incidence were examined in the study. The values of eosinophiles, serum enzymes and serologic response to T. spiralis were determined in relation to the disease severity. Twenty-nine patients, of mean age from 24 to 29 years treated in the Clinic in the period from January to April 1995 were presented-7 with severe form of trichinosis, 10 with moderately severe and 12 with light. The fever was noticed in 93.1% of patients, gastrointestinal disorders in 65.5%, myalgias in 96.6%, facial edema in 79.3%, cardiac disorders in 31% and rash in 20.7%. Positive IIF test result was found in 100% of patients with severe clinical features, and only in 58.3% of patients with light clinical features. The patients were treated with mebendazole in the dose of 25 mg/kg BM a day during 14 days. It was concluded that severe trichinosis forms were frequently followed by myocardial damage, that severe forms responded faster and better serologically to trichinella and those patients should be treated with high mebendazole doses.
Mikić
D
D
Vojnomedicinska akademija, Klinika za infektivne i tropske bolesti, Beograd.
Marinković
V
V
Milosević
N
N
Begović
V
V
Velimirović
S
S
Tavcioski
D
D
D000328:Adult; D000969:Antinematodal Agents / Q000627:therapeutic use; D006801:Humans; D008463:Mebendazole / Q000627:therapeutic use; D014235:Trichinellosis / Q000175:diagnosis* / Q000188:drug therapy
D000969:Antinematodal Agents; D008463:Mebendazole
Klinicko-laboratorijske karakteristike i lecenje bolesnika sa trihinelozom.